273 related articles for article (PubMed ID: 1865744)
41. Botulinum toxin injection for abductor spasmodic dysphonia under cervical ultrasonography guidance.
Kunieda C; Nin F; Ohashi T; Hosokawa K; Watanabe Y; Ogawa T; Mori T; Kanazawa T
Auris Nasus Larynx; 2024 Apr; 51(2):361-364. PubMed ID: 37838568
[TBL] [Abstract][Full Text] [Related]
42. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
[TBL] [Abstract][Full Text] [Related]
43. [Laryngeal dystonia. Comparison of transcutaneous and transoral injection of botulinum toxin].
García Ruiz PJ; Cenjor Español C; Sánchez Pernaute R; Astarloa R; Sánchez Bernardos V; García de Yébenes Prous J
Neurologia; 1996; 11(6):216-9. PubMed ID: 8768677
[TBL] [Abstract][Full Text] [Related]
44. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
Ford CN; Bless DM; Lowery JD
Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
[TBL] [Abstract][Full Text] [Related]
45. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A.
Grillone GA; Blitzer A; Brin MF; Annino DJ; Saint-Hilaire MH
Laryngoscope; 1994 Jan; 104(1 Pt 1):30-2. PubMed ID: 8295454
[TBL] [Abstract][Full Text] [Related]
46. Botulinum toxin for the treatment of spasmodic dysphonia.
Gibbs SR; Blitzer A
Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
[TBL] [Abstract][Full Text] [Related]
47. Botulinum toxin for spasmodic dysphonia.
Rodriquez AA
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036
[TBL] [Abstract][Full Text] [Related]
48. Abductor paralysis after botox injection for adductor spasmodic dysphonia.
Venkatesan NN; Johns MM; Hapner ER; DelGaudio JM
Laryngoscope; 2010 Jun; 120(6):1177-80. PubMed ID: 20513036
[TBL] [Abstract][Full Text] [Related]
49. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results.
Paniello RC; Barlow J; Serna JS
Laryngoscope; 2008 Mar; 118(3):564-8. PubMed ID: 18216744
[TBL] [Abstract][Full Text] [Related]
50. Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral approach.
García Ruiz PJ; Cenjor Español C; Sanchez Bernardos V; Astarloa R; Sanabria J; García de Yébenes J
Clin Neuropharmacol; 1998; 21(3):196-8. PubMed ID: 9617512
[TBL] [Abstract][Full Text] [Related]
51. Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia.
Green DC; Berke GS; Ward PH; Gerratt BR
Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):883-7. PubMed ID: 1444094
[TBL] [Abstract][Full Text] [Related]
52. Longitudinal phonatory characteristics after botulinum toxin type A injection.
Fisher KV; Scherer RC; Guo CG; Owen AS
J Speech Hear Res; 1996 Oct; 39(5):968-80. PubMed ID: 8898251
[TBL] [Abstract][Full Text] [Related]
53. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia.
Inagi K; Ford CN; Bless DM; Heisey D
J Voice; 1996 Sep; 10(3):306-13. PubMed ID: 8865102
[TBL] [Abstract][Full Text] [Related]
54. Histology of nerves and muscles in adductor spasmodic dysphonia.
Chhetri DK; Blumin JH; Vinters HV; Berke GS
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628
[TBL] [Abstract][Full Text] [Related]
55. Acoustic measures of symptoms in abductor spasmodic dysphonia.
Edgar JD; Sapienza CM; Bidus K; Ludlow CL
J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of phonosurgical methods of treatment in spasmodic dysphonia].
Kosztyła-Hojna B; Berger G; Zdrojkowski M
Pol Merkur Lekarski; 2017 Feb; 42(248):90-92. PubMed ID: 28258685
[TBL] [Abstract][Full Text] [Related]
57. Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia.
Bielamowicz S; Squire S; Bidus K; Ludlow CL
Ann Otol Rhinol Laryngol; 2001 May; 110(5 Pt 1):406-12. PubMed ID: 11372922
[TBL] [Abstract][Full Text] [Related]
58. Management of supraglottic squeeze in adductor spasmodic dysphonia: a new technique.
Young N; Blitzer A
Laryngoscope; 2007 Nov; 117(11):2082-4. PubMed ID: 17828055
[TBL] [Abstract][Full Text] [Related]
59. Botulinum Toxin Injections Into the Lateral Cricoarytenoid Muscles for Vocal Process Granuloma.
Pham Q; Campbell R; Mattioni J; Sataloff R
J Voice; 2018 May; 32(3):363-366. PubMed ID: 28778373
[TBL] [Abstract][Full Text] [Related]
60. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture.
Crevier-Buchman L; Laccourreye O; Papon JF; Nurit D; Brasnu D
J Voice; 1997 Jun; 11(2):232-7. PubMed ID: 9181547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
